Michael Alscher News Today

Street Talk understands the private capital firm has nabbed PwC debt and capital specialist Russell Sinclair to oversee its newly established start-up debt fund.

There’s restructuring ahead at the No. 2 pathology provider Healius, which despite its activist ructions, has yielded a 30 per cent return since its 2023 low.

Proxy votes show Jenny Macdonald would have failed in her re-election campaign for the Healius board, which is being targeted by Tanarra Capital.

As summer nears in Australia, Crescent Capital is seeking to capitalise on a turnaround in the iconic swimwear label founded by Jodhi Meares, and once owned by Billabong.

ClearView Wealth has appointed an experienced life industry veteran as non-executive director.

Turns out Australian Clinical Labs’ eccentric bid for bigger rival Healius has not been the only burning item on PE investor Crescent Capital’s to-do list.

Australian Clinical Labs has put an offer to Healius to swap shares in an off-market takeover offer.

The window opened for private equity-backed pathology group Australian Clinical Labs - and it jumped.

After 12 years in the wilderness, the Labor leader thinks the timing is finally right to seize power in NSW.

It’s one in, one out for in private equity’s happy hunting ground, Australia’s childcare sector.